Inventor · disambiguated record
Helen Francis-Lang
Also filed as: FRANCIS-LANG HELEN · FRANCIS-LANG HELEN L · FRANCIS-LANG HELEN LOUISE
15 granted patents·45 pending applications·333 citations·filing 1999–2015
91Inventor score
Top patents by PatentIndex Score
60 records- 0194US6703491B1Drosophila sequencesEXELIXIS INC·Filed 1999·Granted Mar 9, 2004·123 cites·18 claims
- 0294US6511824B1Nucleic acids and polypeptides of invertebrate TWIK channels and methods of useEXELIXIS INC·Filed 1999·Granted Jan 28, 2003·195 cites·5 claims
- 0385US9182385B2Methods for diagnosis, prognosis and methods of treatmentFANTL WENDY J·Filed 2012·Granted Nov 10, 2015·5 cites·18 claims
- 0479US7993829B2HPRP4s modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2007·Granted Aug 9, 2011·2 cites·10 claims
- 0571US7785805B2MAN2As as modifiers of the IGFR pathway and methods of useEXELIXIS INC·Filed 2005·Granted Aug 31, 2010·4 cites·16 claims
- 0669US8426147B2RORS as modifiers of the p21 pathway and methods of useFRANCIS-LANG HELEN·Filed 2008·Granted Apr 23, 2013·2 cites·15 claims
- 0769US7888047B2PDEs as modifiers of the IGFR pathways and methods of useEXELIXIS INC·Filed 2005·Granted Feb 15, 2011·1 cites·22 claims
- 0869US2008102070A1SCDs As Modifiers of the p53 Pathway and Methods of UseEXELIXIS INC·Filed 2007·Application pending·0 cites
- 0968US2008166709A1MARKs as Modifiers of the p53 Pathway and Methods of UseEXELIXIS INC·Filed 2007·Application pending·0 cites
- 1062US2003165966A1MSRAs as modifiers of the p53 pathway and methods of useFiled 2003·Application pending·0 cites
- 1158US2009269773A1Methods of determining the health status of an individualNODALITY INC A DELAWARE CORP·Filed 2009·Application pending·0 cites
- 1257US2008050313A1Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of UseEXELIXIS INC·Filed 2004·Application pending·0 cites
- 1355US2009098594A1Methods for diagnosis prognosis and methods of treatmentNODALITY INC·Filed 2008·Application pending·0 cites
- 1455US2016097770A1Methods for diagnosis, prognosis and methods of treatmentNODALITY INC·Filed 2015·Application pending·0 cites
- 1555US2014134648A1Methods of determining the health status of an individualNODALITY INC·Filed 2013·Application pending·0 cites
- 1654US6972179B2RRP sequences and knockout mice and uses thereofEXELIXIS INC·Filed 2002·Granted Dec 6, 2005·0 cites·5 claims
- 1754US2006160764A1LIMKs as modifiers of p53 pathway and methods of useEXELIXIS INC·Filed 2006·Application pending·0 cites
- 1853US8771942B2SCDs as modifiers of the p53 pathway and methods of useBELVIN MARCIA·Filed 2010·Granted Jul 8, 2014·0 cites·6 claims
- 1953US7049088B2PRMTs as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2002·Granted May 23, 2006·1 cites·2 claims
- 2053US2010042351A1Methods and apparatus related to management of experimentsCOVEY TODD M·Filed 2009·Application pending·0 cites
- 2152US8153384B2Marks as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2010·Granted Apr 10, 2012·0 cites·15 claims
- 2252US2006101530A1Rors as modifiers of the p21 pathway and methods of useFRANCIS-LANG HELEN·Filed 2003·Application pending·0 cites
- 2351US8268548B2MAP3Ks as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2007·Granted Sep 18, 2012·0 cites·12 claims
- 2451US2005227228A1Map3ks as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2002·Application pending·0 cites
- 2550US2003215849A1PDPK1s as modifiers of the p53 pathway and methods of useFiled 2003·Application pending·0 cites
- 2650US2003087266A1IGs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 2750US2003219795A1SCDs as modifiers of the p53 pathway and methods of useFiled 2003·Application pending·0 cites
- 2850US2011159508A1GFATS as Modifiers of the P53 Pathway and Methods of UseEXELIXIS INC·Filed 2010·Application pending·0 cites
- 2948US7943302B2C20ORF23 as modifier of the IGFR pathway and methods of useEXELIXIS INC·Filed 2005·Granted May 17, 2011·0 cites·7 claims
- 3048US2012215481A1Methods and apparatus related to management of experimentsCOVEY TODD M·Filed 2012·Application pending·0 cites
- 3148US2003027230A1HPRP4s as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3247US2009291458A1Method for Determining the Status of an IndividualNODALITY INC·Filed 2009·Application pending·0 cites
- 3347US2005112568A1Dgks as modifiers of the p53 pathwha and methods of useFiled 2002·Application pending·0 cites
- 3447US2003013144A1HS2STs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3547US2005170344A1Chds as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3647US2003165809A1MARKs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3747US2002192695A1PIBs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3847US2003027188A1SLC7s as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3947US2003036076A1CADs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 4046US2006121457A1Gfats as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2002·Application pending·0 cites
- 4146US2007128606A1Prkcs as modifiers of the beta catenin pathway and methods of useEXELIXIS INC·Filed 2004·Application pending·0 cites
- 4246US2013212716A1PFKs as Modifiers of the IGFR Pathway and Methods of UseEXELIXIS INC·Filed 2013·Application pending·0 cites
- 4345US2006063710A1Flj20647s as modifiers of the p21 pathway and methods of useFRANCIS-LANG HELEN·Filed 2003·Application pending·0 cites
- 4444US2005251870A1Csnk1gs as modifiers of the p21 pathway and methods of useEXELIXIS INC·Filed 2003·Application pending·0 cites
- 4544US2007286852A1Sppls as Modifiers of the P53 Pathway and Methods of UseEXELIXIS INC·Filed 2004·Application pending·0 cites
- 4643US7888048B2P4HAS as modifiers of the IGFR pathway and methods of useEXELIXIS INC·Filed 2005·Granted Feb 15, 2011·0 cites·25 claims
- 4742US2011059066A1PAKs as Modifiers of the CHK Pathway and Methods of UseEXELIXIS INC·Filed 2010·Application pending·0 cites
- 4841US2003036078A1P5CRs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 4941US2003165965A1LGALS as modifiers of the CHK pathway and methods of useFiled 2003·Application pending·0 cites
- 5041US2007134732A1Lces as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2002·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →